Objectives: To determine whether interleukin (IL)-6 or soluble tumor necrosis factor alpha receptor 1 (sTNF-αR1) is associated with depressive symptoms in the year after hip fracture.
Design: Prospective cohort.
Setting: Three Baltimore-area hospitals.